Wachtell, Skadden Guide MorphoSys' $1.7B Cancer Co. Buy
Cancer and autoimmune disease-focused MorphoSys AG announced Wednesday that it plans to buy cancer research company Constellation Pharmaceuticals in a $1.7 billion deal guided by Skadden and Wachtell Lipton....To view the full article, register now.
Already a subscriber? Click here to view full article